Bio X Cell’s portfolio of 400+ monoclonal antibodies (mAbs) are used by 1,500+ academic, government and commercial customers in a variety of research areas including cancer, immunology and neuroscience. BXC supplies research use only mAbs to customers in more than 50 countries throughout the Americas, Europe and Asia, and has a growing list of 20,000+ research publication citations.
Complementary life science tools and reagents serving the pre‐clinical research market